To evaluate the efficacy and safety of Longvida capsule in the patients suffering from knee osteoarthritis.
- Conditions
- Health Condition 1: null- Patients suffering from knee osteoarthritis.
- Registration Number
- CTRI/2015/07/006061
- Lead Sponsor
- Pharmanza Herbal PvtLtd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Patients of either sex, 40 to 60 years of age diagnosed with osteoarthritis of the knee based on the American College of Rheumatology (ACR)criteria and patient willing to comply with study procedures and requirements.
1.Patients with congenital arthropathy, rheumatoid arthritis, active gout, other type of arthritis with/without inflammation e.g. septic , fibromyalgia or collagen vascular disease
2.Patients with known history of coagulopathies
3.Osteoarthritis of any other joint except knee
4.Patients with history of major trauma or surgery in the knee joint
5.Patients with uncontrolled diabetes and hypertension
6.Body mass index (BMI) >40 kg/m2.
7.Patients with any severe cardiac, renal and hepatic disease
8.Pregnant and lactating women
9.Patients who participated in any clinical trial within 30 days before enrollment into the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method